The Emerging Role of Flavonoids in Autism Spectrum Disorder: A Systematic Review
Journal of Clinical Medicine · 17.05.2023 · 12 (10) · 3520
DOI: 10.3390/jcm12103520 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 17.05.2023. Verfasst von Rosa Savino und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Woman and Child, Neuropsychiatry for Child and Adolescent Unit, General Hospital "Riuniti" of Foggia, 71122 Foggia, Italy. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Although autism spectrum disorder (ASD) is a multifaceted neurodevelopmental syndrome, accumulating evidence indicates that oxidative stress and inflammation are common features of ASD. Flavonoids, one of the largest and best-investigated classes of plant-derived compounds, are known to exert antioxidant, anti-inflammatory, and neuroprotective effects. This review used a systematic search process to assess the available evidence on the effect of flavonoids on ASD. A comprehensive literature search was carried out in PubMed, Scopus, and Web of Science databases following the PRISMA guidelines. A total of 17 preclinical studies and 4 clinical investigations met our inclusion criteria and were included in the final review. Most findings from animal studies suggest that treatment with flavonoids improves oxidative stress parameters, reduces inflammatory mediators, and promotes pro-neurogenic effects. These studies also showed that flavonoids ameliorate the core symptoms of ASD, such as social deficits, repetitive behavior, learning and memory impairments, and motor coordination. However, there are no randomized placebo-controlled trials that support the clinical efficacy of flavonoids in ASD. We only found open-label studies and case reports/series, using only two flavonoids such as luteolin and quercetin. These preliminary clinical studies indicate that flavonoid administration may improve specific behavioral symptoms of ASD. Overall, this review is the first one to systematically report evidence for the putative beneficial effects of flavonoids on features of ASD. These promising preliminary results may provide the rationale for future randomized controlled trials aimed at confirming these outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Woman and Child, Neuropsychiatry for Child and Adolescent Unit, General Hospital "Riuniti" of Foggia, 71122 Foggia, Italy.
- Department of Medicine and Health Sciences "V. Tiberio", University of Molise, 86100 Campobasso, Italy.
- Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
ORCID-Profile: Rosa Savino, Alessandro Medoro, Giovanni Scapagnini, Sergio Davinelli
Zitieren
APA
Savino, R., Medoro, A., Ali, S., Scapagnini, G., Maes, M., & Davinelli, S. (2023). The Emerging Role of Flavonoids in Autism Spectrum Disorder: A Systematic Review. Journal of Clinical Medicine, 12(10), 3520. https://doi.org/10.3390/jcm12103520
Vancouver
Savino R, Medoro A, Ali S, Scapagnini G, Maes M, Davinelli S. The Emerging Role of Flavonoids in Autism Spectrum Disorder: A Systematic Review. Journal of Clinical Medicine. 2023;12(10):3520. doi:10.3390/jcm12103520
BibTeX
@article{Savino2023,
author = {Savino, Rosa and Medoro, Alessandro and Ali, Sawan and Scapagnini, Giovanni and Maes, Michael and Davinelli, Sergio},
title = {The Emerging Role of Flavonoids in Autism Spectrum Disorder: A Systematic Review},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {10},
pages = {3520},
doi = {10.3390/jcm12103520}
}
EUVIMED